Gallacher Capital Management’s Harmony Biosciences HRMY Stock Holding History

Gallacher Capital Management’s Portfolio HRMY Stock Details HRMY Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$243K	Sell	6,666 -6,003	-47%	-$189K	0.14%	229
2026 Q1	$355K	Sell	12,669 -3,021	-19%	-$99.1K	0.14%	203
2025 Q4	$587K	Sell	15,690 -401	-2%	-$13.2K	0.23%	131
2025 Q3	$443K	Buy	16,091 +6,110	+61%	+$210K	0.18%	190
2025 Q2	$315K	Buy	9,981 +413	+4%	+$13.3K	0.15%	202
2025 Q1	$318K	Buy	+9,568	New	+$343K	0.15%	187

Other funds holding HRMY

CX Institutional Auburn, Indiana $3.46B AUM 21.89% 1-Year Est. Return

Robeco Institutional Asset Management Rotterdam, Netherlands $81.4B AUM 40.71% 1-Year Est. Return

ETC

Exchange Traded Concepts Oklahoma City, Oklahoma $21.9B AUM 68.6% 1-Year Est. Return

WCM

Wedge Capital Management Charlotte, North Carolina $6.06B AUM 47.24% 1-Year Est. Return

CAMG

CWA Asset Management Group Naples, Florida $3.28B AUM 34.07% 1-Year Est. Return

YIH

Y-Intercept (HK) Hong Kong $5.05B AUM 17.89% 1-Year Est. Return

HWAM

Hennion & Walsh Asset Management Parsippany, New Jersey $3.5B AUM 41.95% 1-Year Est. Return

Paradiem Covington, Louisiana $464M AUM 45.56% 1-Year Est. Return

New York State Teachers Retirement System (NYSTRS) Albany, New York $54.2B AUM 43.77% 1-Year Est. Return

SOADOR

State of Alaska Department of Revenue Juneau, Alaska $10.1B AUM 42.83% 1-Year Est. Return

Gallacher Capital Management's HRMY Position: Q2 2026 in Review

Gallacher Capital Management reduced its Harmony Biosciences (HRMY) stake by 47% in Q2 2026, selling an estimated $189K and leaving 6,666 shares worth $243K. The position accounts for 0.14% of the portfolio, ranked #229.

Gallacher Capital Management first reported a position in HRMY in Q1 2025 and has held it in 6 quarters since. The position peaked at $587K in Q4 2025. 46 funds tracked by Wall St. Rank hold HRMY as of Q2 2026.

Gallacher Capital Management held 6,666 shares of Harmony Biosciences worth $243K as of Q2 2026.
Gallacher Capital Management sold 6,003 Harmony Biosciences shares in Q2 2026, an estimated $189K.
Harmony Biosciences made up 0.14% of Gallacher Capital Management's portfolio in Q2 2026, its #229 holding.
Gallacher Capital Management first reported a position in Harmony Biosciences in Q1 2025 and has held it in 6 quarters since.
Gallacher Capital Management's Harmony Biosciences position peaked at $587K in Q4 2025.
46 funds tracked by Wall St. Rank held Harmony Biosciences as of Q2 2026.

Based on Gallacher Capital Management's 13F filing for Q2 2026, filed 17 Jul 2026.